BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16887883)

  • 1. Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells.
    Bonofiglio D; Aquila S; Catalano S; Gabriele S; Belmonte M; Middea E; Qi H; Morelli C; Gentile M; Maggiolini M; Andò S
    Mol Endocrinol; 2006 Dec; 20(12):3083-92. PubMed ID: 16887883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
    Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S
    Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Qi H; Belmonte M; Catalano S; Andò S
    Breast Cancer Res Treat; 2009 Feb; 113(3):423-34. PubMed ID: 18293083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism.
    Ghorbani A; Nazari M; Jeddi-Tehrani M; Zand H
    Eur J Nutr; 2012 Feb; 51(1):39-46. PubMed ID: 21445621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
    Han S; Sidell N; Fisher PB; Roman J
    Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RXR antagonism induces G0 /G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes.
    Nakatsuka A; Wada J; Hida K; Hida A; Eguchi J; Teshigawara S; Murakami K; Kanzaki M; Inoue K; Terami T; Katayama A; Ogawa D; Kagechika H; Makino H
    J Pathol; 2012 Apr; 226(5):784-95. PubMed ID: 21956786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
    Pandhare J; Cooper SK; Phang JM
    J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
    Yang YC; Tsao YP; Ho TC; Choung IP
    Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
    Liu Y; Dai B; Fu L; Jia J; Mei C
    Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells.
    Bonofiglio D; Cione E; Vizza D; Perri M; Pingitore A; Qi H; Catalano S; Rovito D; Genchi G; Andò S
    Cell Cycle; 2011 Jul; 10(14):2344-54. PubMed ID: 21654191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.
    Rovito D; Gionfriddo G; Barone I; Giordano C; Grande F; De Amicis F; Lanzino M; Catalano S; Andò S; Bonofiglio D
    Oncotarget; 2016 Oct; 7(40):65109-65124. PubMed ID: 27556298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
    Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.